Jiyeon Ock

Jiyeon Ock

Auto-generated profile, based on publicly available information

Jiyeon Ock

National Research Center for Sexual Medicine and Department of Urology, Inha University School of Medicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2013 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
CLCheryl Leong
Cheryl Leong
SLSung Chan Lee
Sung Chan Lee
JOJiyeon Ock
Jiyeon Ock
XLXin Li
Xin Li
PSPeter See
Peter See
YCYoung-Tae Chang
Young-Tae Chang
Small molecule fluorescent probes offer significant advantages over conventional antibody and fluorescent protein labeling techniques. Here we present CDr10a and CDr10b, dyes that label live microglia specifically. They may be applied to the isolation and imaging of live microglia when investigating their role in neuroinflammatory diseases.

1 January 2020 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
KSKang-Moon Song
Kang-Moon Song
DCDoo Yong Chung
Doo Yong Chung
MCMin Ji Choi
Min Ji Choi
KGKalyan Ghatak
Kalyan Ghatak
NMNguyen Nhat Minh
Nguyen Nhat Minh
JSJun-Kyu Suh
Jun-Kyu Suh
Song KM, et al. World J Mens Health. 2019 Jan;37:e50. https://doi.org/10.5534/wjmh.190071

1 January 2021 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
GYGUONAN YIN
GUONAN YIN
JOJiyeon Ock
Jiyeon Ock
MCMin-Ji Choi
Min-Ji Choi
ALAnita Limanjaya
Anita Limanjaya
KGKalyan Ghatak
Kalyan Ghatak
JRJi-Kan Ryu
Ji-Kan Ryu
Yin GN, et al. Investig Clin Urol. 2021 Jan;62(1):90-99. https://doi.org/10.4111/icu.20200119

1 January 2020 in The World Journal of Men's Health
Verified
Journal Article
Open access
GYGUONAN YIN
GUONAN YIN
JOJiyeon Ock
Jiyeon Ock
MCMin-Ji Choi
Min-Ji Choi
KSKang-Moon Song
Kang-Moon Song
KGKalyan Ghatak
Kalyan Ghatak
JSJun-Kyu Suh
Jun-Kyu Suh
To establish a simple and nonenzymatic technique to isolate endothelial cells (ECs) and pericytes from human corpus cavernosum tissue and to evaluate the angiogenic ability of the human cavernous EC or pericytes for the study of high glucose-induced angiopathy. For primary human cavernous EC culture, cavernous tissues were implanted into Matrigel in dishes. For primary human cavernous pericyte culture, cavernous tissues were settled by gravity into dishes. We performed immunocytochemistry and Western blot to determine phenotype and morphologic changes from passage 1 to 5. The primary cultured cells were exposed to a normal-glucose (5 mmol/L) or a high-glucose (30 mmol/L) condition, and then tube formation assay was done. We successfully isolated high-purity EC and pericytes from human corpus cavernosum tissue. Primary cultured EC showed highly positive staining for von Willebrand factor, and pericyte revealed positive staining for NG2 and platelet-derived growth factor receptor-β. Primary cultured EC and pericytes maintained their cellular characteristics up to passage 2 or 3. However, we observed significant changes in their typical phenotype from the passage 4 and morphological characteristics from the passage 3. Human cavernous EC or pericytes formed well-organized capillary-like structures in normal-glucose condition, whereas severely impaired tube formation was detected in high-glucose condition. This study provides a simple and nonenzymatic method for primary culture of human cavernous EC and pericytes. Our study will aid us to understand the pathophysiology of diabetic erectile dysfunction, and also be a valuable tool for determining the efficacy of candidate therapeutic targets.

7 August 2022 in Andrology
Verified
Journal Article
Open access
JOJiyeon Ock
Jiyeon Ock
JSJun‐Kyu Suh
Jun‐Kyu Suh
SHSoon‐Sun Hong
Soon‐Sun Hong
JKJu-Hee Kang
Ju-Hee Kang
GYGUONAN YIN
GUONAN YIN
JRJi-Kan Ryu
Ji-Kan Ryu
Background: The incidence of diabetic erectile dysfunction (ED) is rapidly increasing, and due to the severe angiopathy caused by diabetes, current drugs are ineffective at treating ED. Insulin‐like growth factor‐binding protein 5 (IGFBP5) promotes cell death and induces apoptosis in various cell types.Objectives: To evaluate the effectiveness of IGFBP5 knockdown in improving erectile function in diabetic mice.Materials and methods: Diabetes was induced by injecting streptozotocin (STZ) intraperitoneally into male 8‐week‐old C57BL/6 mice. Eight weeks after diabetes induction, mice were divided into four groups: a nondiabetic control group and three STZ‐induced diabetic mice groups, which were administered intracavernous injections of phosphate buffered saline, scrambled control shRNA, or shRNA targeting mouse IGFBP5 (shIGFBP5) lentivirus particles. Two weeks later, we measured erectile function by electrically stimulating the bilateral cavernous nerve. To mimic diabetic angiopathy, primary cavernous endothelial cells (MCECs) from healthy mice were cultured and treated with glucose.Results: IGFBP5 expression in MCECs or cavernous tissues were significantly increased under diabetic conditions, and knockdown of IGFBP5 induced MCECs angiogenic activity under high‐glucose conditions. STZ‐induced diabetic mice had reduced erectile function, but shIGFBP5 treatment resulted in significant improvements (to 90% of the nondiabetic control group level). Furthermore, in diabetic mice, numbers of cavernous endothelial cells, pericytes, and neuronal cells were increased by shIGFBP5 treatment, which also increased eNOS Ser1177 phosphorylation, decreased permeability and apoptosis of cavernous endothelial cells. In addition, IGFBP5 was found to mediate the AKT, ERK, p38 signaling pathways.Discussion and conclusion: Knockdown of IGFBP5 improved erectile function in diabetic mice by promoting cell proliferation and reducing apoptosis and permeability. Local inhibition of IGFBP5 expression may provide a new treatment strategy for diabetic ED and other ischemic vascular or neurological diseases.